Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priscilla S Redd

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scientific Reports|August 5, 2016
Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytesGenevieve L Coe, Priscilla S Redd, Amy V Paschall, et al.
Frontiers in Cell and Developmental Biology|June 26, 2023
Transposase expression, element abundance, element size, and DNA repair determine the mobility and heritability of <i>PIF</i>/<i>Pong</i>/<i>Harbinger</i> transposable elementsPriscilla S Redd, Lisette Payero, David M Gilbert, et al.
Oncotarget|September 24, 2016
CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotypeAmy V Paschall, Dafeng Yang, Chunwan Lu, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Cell Reports|December 13, 2018
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon TumorigenesisMohammed L Ibrahim, John D Klement, Chunwan Lu, et al.
Cancer Cell|March 14, 2023
Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitmentJohn D Klement, Priscilla S Redd, Chunwan Lu, et al.
Journal for Immunotherapy of Cancer|August 1, 2025
Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasisKendra Fick, Nicholas Kerns, Yang Zhao, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Distinct and cooperative roles of host and tumor Osteopontin in colorectal cancer liver metastasisPatrick Czabala, Yang Zhao, John D Klement, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Multi-compartment immune and tumor cell reprogramming by IFNα2 overcomes colon cancer immunotherapy resistanceZainab Tiamiyu, Patrick Czabala, Jennifer Worthy, et al.
Plant Direct|January 28, 2021
Development of <i>mPing</i>-based activation tags for crop insertional mutagenesisAlexander Johnson, Edward Mcassey, Stephanie Diaz, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|August 5, 2016
Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytesGenevieve L Coe, Priscilla S Redd, Amy V Paschall, et al.
Frontiers in Cell and Developmental Biology|June 26, 2023
Transposase expression, element abundance, element size, and DNA repair determine the mobility and heritability of <i>PIF</i>/<i>Pong</i>/<i>Harbinger</i> transposable elementsPriscilla S Redd, Lisette Payero, David M Gilbert, et al.
Oncotarget|September 24, 2016
CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotypeAmy V Paschall, Dafeng Yang, Chunwan Lu, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Cell Reports|December 13, 2018
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon TumorigenesisMohammed L Ibrahim, John D Klement, Chunwan Lu, et al.
Cancer Cell|March 14, 2023
Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitmentJohn D Klement, Priscilla S Redd, Chunwan Lu, et al.
Journal for Immunotherapy of Cancer|August 1, 2025
Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasisKendra Fick, Nicholas Kerns, Yang Zhao, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Distinct and cooperative roles of host and tumor Osteopontin in colorectal cancer liver metastasisPatrick Czabala, Yang Zhao, John D Klement, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Multi-compartment immune and tumor cell reprogramming by IFNα2 overcomes colon cancer immunotherapy resistanceZainab Tiamiyu, Patrick Czabala, Jennifer Worthy, et al.
Plant Direct|January 28, 2021
Development of <i>mPing</i>-based activation tags for crop insertional mutagenesisAlexander Johnson, Edward Mcassey, Stephanie Diaz, et al.
Pageof 3